Washington University School of Medicine

Digital Commons@Becker
Open Access Publications

2015

Functional heterogeneity in CD4+ T cell responses
against a bacterial pathogen
Ashley Viehmann Milam
Washington University School of Medicine in St. Louis

Paul M. Allen
Washington University School of Medicine in St. Louis

Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
Recommended Citation
Milam, Ashley Viehmann and Allen, Paul M., ,"Functional heterogeneity in CD4+ T cell responses against a bacterial pathogen."
Frontiers in Immunology.6,. 621. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4451

This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.

Mini Review
published: 11 December 2015
doi: 10.3389/fimmu.2015.00621

Functional Heterogeneity in CD4+
T Cell Responses Against a Bacterial
Pathogen
Ashley Viehmann Milam and Paul M. Allen*
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA

Edited by:
Eric Huseby,
University of Massachusetts Medical
School, USA
Reviewed by:
António Gil Castro,
University of Minho, Portugal
David K. Cole,
Cardiff University, UK
*Correspondence:
Paul M. Allen
allen@pathology.wustl.edu
Specialty section:
This article was submitted to T Cell
Biology,
a section of the journal
Frontiers in Immunology
Received: 01 October 2015
Accepted: 30 November 2015
Published: 11 December 2015
Citation:
Milam AV and Allen PM (2015)
Functional Heterogeneity in CD4+
T Cell Responses Against a Bacterial
Pathogen.
Front. Immunol. 6:621.
doi: 10.3389/fimmu.2015.00621

To investigate how CD4+ T cells function against a bacterial pathogen, we generated a
Listeria monocytogenes-specific CD4+ T cell model. In this system, two TCRtg mouse
lines, LLO56 and LLO118, recognize the same immunodominant epitope (LLO190-205) of
L. monocytogenes and have identical in vitro responses. However, in vivo LLO56 and
LLO118 display vastly different responses during both primary and secondary infection.
LLO118 dominates in the primary response and in providing CD8 T cell help. LLO56
predominates in the secondary response. We have also shown that both specific [T
cell receptor (TCR)-mediated] and non-specific stimuli (bypassing the TCR) elicit distinct
responses from the two transgenics, leading us to conclude that the strength of selfpMHC signaling during development tightly dictates the cell’s future response in the
periphery. Herein, we review our findings in this transfer system, focusing on the contribution of the immunomodulatory molecule CD5 and the importance of self-interaction in
peripheral maintenance of the cell. We also discuss the manner in which individual TCR
affinities to foreign and self-pMHC contribute to the outcome of an immune response;
our assertion is that there exists a spectrum of possible T cell responses to recognition
of cognate antigen during infection, adding immense diversity to the immune system’s
response to pathogens.
Keywords: CD4+ T cell, CD5, Listeria monocytogenes, immunomodulation, self-peptide, thymocytes, regulatory
T cell

INTRODUCTION
The interaction of the T cell antigen receptor with its cognate antigen is essential for an adaptive
immune response and involves the interaction between the T cell receptor (TCR) and peptide bound
to an major histocompatibility molecule (MHC). Long before T cells meet cognate antigen in the
periphery; however, they proceed through rigorous positive and negative selection in the thymus,
according to the affinity of their rearranged TCR for self-peptide presented on self-MHC on thymic
antigen-presenting cells (APCs).
The process of VDJ recombination and pairing of α and β chains allows for an astonishingly diverse
panel of possible TCRs (1–3). There is a surprising level of redundancy inherent in the outcome of the
combined processes of VDJ recombination and thymic selection, with a relatively limited number of
unique TCRs able to recognize a broad spectrum of pathogen-derived antigens. There also exists the
(non-mutually exclusive) phenomenon of multiple TCRs capable of recognizing the same peptide/
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MHC with similar affinities. What is the evolutionary advantage
of such redundancy? It should be considered that heterogeneity
in signaling responses following TCR engagement allows for the
establishment of a full complement of key immune system players. This includes both effector and memory CD4+ and CD8+ T
cells. Within the CD4+ T cell compartment, further specialization
is accomplished via skewing of helper T (Th) cells, which produce
key cytokines necessary for a full immune response and provide
help to responding CD8+ T cells, and induction of regulatory T
cells (Tregs) capable of preventing inflammatory damage during
an otherwise overzealous immune response.
So, how do individual TCR affinities to foreign and selfpMHC contribute to the outcome of an immune response? To
better address this question, we have designed a T cell system
involving transfer of two congenically marked TCR-transgenic
T cells (LLO56 and LLO118), both recognizing the same Listeria
monocytogenes-derived epitope. The T cells are transferred into
normal B6 recipient mice, which are in turn infected with L.
monocytogenes. In vitro, these two naïve T cells have very similar
antigen responses to both peptide and intact Listeria. Not until
they are activated in vivo can one appreciate the vastly different
potential of the two. One, LLO118, responds robustly during primary infection, only to make a poor showing during a secondary
response, where LLO56 dominates. Unlike LLO118, LLO56 is
highly apoptotic following the primary immune response.
Differential expression of CD5 associated with the two TCRs
helps explain their differing in vivo phenotypes. Intriguingly,
these cells diverge in their response to both antigen-specific
stimuli and non-specific stimuli, which bypasses TCR signaling altogether, indicating that self-peptide-dictated imprinting
during thymic selection and maintenance in the periphery can
critically affect all aspects of behavior throughout the lifespan
of a T cell.

have similar functional affinities for LLO190-205/I-Ab, as measured
by their in vitro proliferative response to peptide stimulation or
stimulation with L. monocytogenes-infected splenocytes. Surface
plasmon resonance (SPR) analysis of the soluble LLO118 and
LLO56 TCR interaction with LLO190-205/I-Ab revealed that they
have the same overall affinity (KD).
In our standard transfer system, 3 × 103 congenically marked,
CD4+ T cell-enriched bead sorted cells from LLO56 Rag1−/− and
LLO118 Rag1−/− mice are co-transferred into B6 recipient mice
via intravenous (IV) retro orbital injection on day 0. On day 1,
recipient mice are infected (IV) with 103 CFU L. monocytogenes
(1043S). Mice are then sacrificed at day 7 to interrogate the primary immune response. To analyze the recall response, mice are
re-infected with 105 CFU L. monocytogenes on day 35 and then
sacrificed on day 39.
LLO56 and LLO118 respond distinctly at both the primary
and secondary time points. Annexin V staining reveals that
LLO56 are highly apoptotic by day 7 (4). LLO118 are recovered
from the spleens of recipient mice at a ratio of ~5:1 the number
of LLO56 recovered. This ratio holds even as the numbers of
injected cells are increased 10-fold or if LLO56 and LLO118 cells
are transferred into separate mice. Therefore, the difference in
response is not due to MHC-antigen competition nor a limited
proliferative niche, but rather inherent differences in the capacity
of the two cell types to respond to infection.
Interestingly, the secondary response in our transfer model is
dominated by LLO56 cells, which outstrip LLO118 cells at a ratio
of ~10:1. We hypothesize that this is due at least in portion to the
massive downregulation of TCR levels observed on LLO118 cells
recovered after a primary infection (4). Starting at day 8, this difference in TCR mean fluorescence intensity (MFI) in the two cells is
on the order of 1–1.5 logs, and it has been shown that TCR downregulation can greatly reduce the proliferative ability of T cells (6).
We also compared the ability of LLO56 and LLO118 to
provide CD4+ T cell help for a CD8+ T cell response in the
context of a primary L. monocytogenes infection. Using a transfer
model similar to that described above, with the addition of the
L. monocytogenes-OVA system, we found equal numbers of
OVA-specific CD8+ T cells (as measured by tetramer staining)
in mice co-injected with either LLO56 or LLO118 CD4+ T cells
during a primary response. However, significantly more OVAspecific CD8+ T cells were found after a recall response in mice
co-transferred with LLO118 CD4+ T cells. Thus, the more robust
LLO118 primary response correlates with a better CD8+ T cell
response after secondary infection (4).
Further insight into the proliferative and memory-forming
capacities of these cells was achieved using analysis of three
different mathematical models that considered the differentiation of naïve cells first into effector and then memory cells.
While the three models reach no consensus on a difference
in the rate of m
 emory cell formation in LLO56 and LLO118
cells, LLO56 memory T cells are predicted to have a halflife nearly three times longer than LLO118 memory T cells
56
t1118
This
predicted
/ 2 ≈ 4.3 − 5d vs. t1/ 2 ≈ 11.5 − 13.9 days .
difference in memory maintenance would explain the better
performance of LLO56 during a recall response (7).

DERIVATION AND CHARACTERIZATION
OF LISTERIOLYSIN O-SPECIFIC TCRTRANSGENIC MICE
The T cell receptors of the LLO56 and LLO118 mouse lines were
originally cloned from a panel of T cell hyrbidomas generated
from B6 mice infected with L. monocytogenes. The two TCRs
recognize the same immunodominant epitope of listeriolysin
O (LLO190-205/I-Ab), and both express Vα2 and Vβ2. The TCR
sequences of these cells are nearly identical, differing by only 15
amino acids in the complementary determining regions (CDRs).
Flow cytometry-based analysis of the two transgenics shows
that LLO56 and LLO118 have similar naïve phenotypes, the
only notable exception being their expression of CD5, a negative
regulator of T cell activation (4). CD5 surface expression correlates with TCR self-reactivity, as CD5 levels are determined
during thymic T cell development according to the strength of
signal perceived via TCR–self-pMHC engagement during thymic
T cell development (5). The LLO56 mouse expresses significantly
higher levels of CD5 on mature thymocytes, splenocytes, and
peripheral lymph node (LN) CD4+ T cells. LLO56 and LLO118
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T CELL RESPONSIVENESS TO SPECIFIC
AND NON-SPECIFIC STIMULI IS SET
DURING THYMIC DEVELOPMENT AND
MAINTAINED IN THE PERIPHERY

into H-2M-deficient mice lost sensitivity to stimulation via
PMA plus ionomycin, as measured by IL-2 production and
ERK phosphorylation and were similar to the LLO118 cells.
Likewise, we also observed reduced ERK phosphorylation
in LLO56 cells transferred into MHC class II-deficient mice
(8). These behavioral changes were noticeable as early as
24 h post-transfer. These findings indicated that continued
TCR–self-peptide–MHC ligation is critical for the preservation of T cell responsiveness.

In vitro analysis of LLO56 and LLO118 revealed inherent differences in the manner in which the two TCRs to respond to
stimulus, be it antigen specific (that is, perceived through the
TCR) or non-specific. When LLO56 and LLO118 were stimulated in vitro with either their cognate antigen or a combination
of anti-CD3/anti-CD28, both cells upregulated CD25 and CD69,
and produced IL-2 (8). However, LLO56 produces nearly twice as
much IL-2 as LLO118 at higher peptide (or anti-CD3/28) concentrations. However, LLO56 also produced more IL-2 in response to
treatment with PMA plus ionomycin, which stimulate signaling
downstream of the TCR. Further examination of the pathways
activated by PMA plus ionomycin also showed increased phosphorylated Erk (pErk) in LLO56 in response to non-specific
stimuli, as well as higher basal p21 (increased basal levels of
phosphorylated TCRζ). These findings indicate that naïve LLO56
and LLO118 emerge from the thymus distinct in their capacities
to respond to both cognate antigen and non-specific stimulation.
While their in vitro affinities for LLO190-205/I-Ab are similar, their
avidities (the strength of signal actually perceived by the cell via
the TCR) clearly differ.
To better understand the behavioral divergence of these
two transgenics, we interrogated thymocytes from LLO56 and
LLO118 mice at each stage of development. Although the absolute cellularity of the thymus in the LLO118 mouse is greater,
we found that the frequency of CD4+ single-positive (SP)
thymocytes to be greater in the LLO56 mouse. This suggests
that selection of CD4+CD8+ double-positive (DP) thymocytes
is more efficient in the context of the LLO56 TCR. While
pre-selection DP thymocytes from both mice are refractory to
PMA plus ionomycin stimulation, we found a population of
CD4+SP thymocytes in both LLO56 and LLO118 mice producing IL-2; this population is significantly greater in the LLO56
mice. Likewise, phospho-ERK staining is higher in CD4+SP
LLO56 thymocytes. We also observed greater Annexin V and
7-aminoactinomycin-D (7-AAD) staining in post-selection
LLO56 thymocytes than in LLO118 thymocytes, indicating that
increased cell death accompanies increased basal ERK phosphorylation, according to TCR self-reactivity and as established in
developing thymocytes (8).
Since we had documented the importance of self-pMHC
education in the earliest development of LLO56 and LLO118,
we sought to determine whether continued tonic selfpeptide–MHC signaling was necessary for their peripheral
maintenance and responsiveness. To accomplish this, LLO56
splenocytes were transferred to H-2M deficient mice, which
fail to present a normal range of processed peptides due to
the fact that nearly all MHC class II molecules are occupied
by class II invariant chain-associated peptide (CLIP). LLO56
cells were then recovered and purified, and their responsiveness to non-specific stimuli tested. Unlike their counterparts
transferred into wild-type B6 mice, LLO56 cells transferred
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CD5 AND THE DYNAMICS OF LLO TCRtg
T CELL RESPONSES
CD5 belongs to group B of the scavenger-receptor cysteine-rich
(SRCR) superfamily; the extracellular portion of CD5 consists
of three SRCR repeats. In mice, the Cd5 gene encodes a 67-kDa
monomeric membrane-spanning glycoprotein expressed on
thymocytes, mature CD4+ and CD8+ T cells, as well as peritoneal
B-1 B cells and subsets of dendritic cells (9–12). CD5 speciesspecific homophilic binding can lead to productive engagement;
other CD5 ligands have been reported, but none have been
independently verified (13). The molecular mass and expression
pattern of CD5 in humans is similar to that in mice. Indeed, the
high level of conservation of the Cd5 gene throughout mammalian and avian species suggests an ancient and critical role for
CD5 in the immune system (14–17). The finding that a naturally
occurring soluble form of CD5 is a pattern-recognition receptor
(PRR), which is capable of recognizing fungal β-glucan (but not
components of bacterial cell wall), reinforces the evolutionary
significance of this molecule (18).
The role of CD5 as an immunomodulatory cell surface
molecule has been appreciated since the publication of the Cd5knockout mouse (15, 19). CD5 is capable of regulating signaling
via both the TCR and the B cell receptor (BCR). In the absence
of CD5, thymocytes are hyperresponsive to antigen stimulation
(as measured by Ca2+ signaling) and peritoneal B-1 cells, levels
of which are elevated in certain autoimmune diseases, become
resistant to apoptosis and instead enter the cell cycle. However,
CD5-knockout mice do not develop significant overt immunity
(19, 20). In addition to its expression on peripheral effector T cells,
CD5 is also expressed on CD4+ Tregs. While CD5 is dispensable
for thymic Treg development (21), peripheral Treg induction is
impaired in its absence (22).
The immunomodulatory nature of CD5 is independent of
its extracellular domains, but an intact cytoplasmic domain is
required for its inhibitory function (23, 24). CD5 localizes to
the immune synapse at the onset of TCR signaling (25). The
intracellular domain of CD5 contains four potential tyrosine
phosphorylation sites, including an immunoreceptor tyrosinebased activation motif (ITAM), immunoreceptor tyrosine-based
inhibition motif (ITIM), and several potential serine/threonine
phosphorylation sites (26). In this way, CD5 is able to recruit
both negative and positive regulators of B and T cell signaling
(27). CD5 is tyrosine phosphorylated upon TCR engagement,
and coprecipitaiton studies have demonstrated that CD5 associates with CD2 and CD4 or CD8, as well as with TCR ζ/Zap70,
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These observations also bring up relevant findings regarding
CD5 expression and the induction of peripheral Tregs. Henderson
and colleagues recently reported that peripheral induction of
CD4+ Tregs is decreased in CD5lo cells and cells from CD5−/−
mice. They found that low levels of effector cytokines produced
by bystander lymphocytes inhibited Treg conversion in these
mice. In CD5 intact mice, on the other hand, CD5hi cells are
able to mitigate this inhibition of Treg induction via blockade
of mammalian target of rapamycin (mTOR) signaling (22). This
study reinforces the findings of Martin and colleagues, who
showed that Ly6Clo and Ly6Chi naïve CD4+ T cells have intrinsic
differences when it comes to their abilities to differentiate into
Tregs in the periphery. The authors demonstrated that Ly6C
expression was tuned in the periphery according to TCR-based
self-recognition, and that more self-reactive cells exhibited lower
surface levels of Ly6C. In turn, they showed that Ly6Clo cells had
significantly higher levels of CD5 and were more likely to differentiate into Tregs in the periphery (35). These findings, along
with the observation that minimal doses of strong agonist peptides can efficiently induce Treg differentiation in the periphery,
suggests a dual role for CD5 (35, 36). Clearly, CD5 serves as a
marker of self-reactivity on both thymocytes and lymphocytes.
Strong CD5 expression “tags” these self-reactive naïve cells as
those most likely to become activated, with great specificity
and intensity, during an immune response. At the same time,
CD5 also serves as an “insurance policy,” helping keep these
potentially destructive cells from initiating autoimmunity and
instead dedicating them, via induction of Treg programming,
to the protection of the organism in question from a potentially
devastating inflammatory episode.
Although only the LLO system is reviewed herein, it stands
to reason that these findings can be extended to other models
of infectious disease. Presumably, during an infection, there will
be a large number of foreign antigens presented to T cells, which
in turn will have been selected on a wide variety of self-antigens
during thymic development and will therefore express varying
levels of CD5. By extension of our findings, we would predict
that within this T cell compartment are cells that will respond
robustly (in terms of effector function, B cell help, T cell help,
and/or regulatory function) and cells that will respond to a lesser
degree, giving breadth to the immune response as a whole.

Lck, Fyn, SHP-1, and CK2. SHP-1 binding to the intracellular
ITIM motif mediates the immunomodulatory behavior of CD5
(28–33).
Considerable work has been done to show the precision
with which CD5 expression is regulated during thymic development. CD5 expression on pre-selection double-negative
(DN) thymocytes is minimal; these developing thymocytes
require pre-TCR engagement for upregulation of CD5 to be
observed (5). CD5 levels increase approximately sixfold on DP
thymocytes and reach maximal levels on post-selection CD4+
and CD8+SP thymocytes, where expression is finely tuned
according to TCR levels and the overall perceived strength of
signal during selection (5). CD5 levels are then maintained as
thymocytes egress from the thymus and join peripheral circulation. These findings have been extended to commonly used
TCR-transgenic mouse models AND (CD4+ TCR transgenic
recognizing moth cytochrome c), H-Y (CD4+ TCR transgenic
recognizing the male Y antigen), P14 (CD8+ TCR transgenic
recognizing LCMV gp33-41), and DO10 (CD8+ TCR transgenic
recognizing OVA). Examination of thymocytes from these mice
revealed higher CD5 levels on AND than on H-Y, and higher
CD5 levels on P14 than on DO10. Likewise, larger CD4+SP
thymocyte populations are observed in AND relative to H-Y,
and larger CD8+SP populations are observed in P14, relative
to DO-10 (5). A study using the DO10 mouse in the context
of both H-2d and H-2b-mediated antigen presentation echoed
these findings, as did another that extended findings on the relationship between CD5 expression and self-reactivity to a larger
panel of TCR transgenics (23, 34). The CD5 levels studied are
maintained on peripheral lymphocytes, reinforcing the finding
that CD5 expression is carefully tuned during thymic selection
according to TCR–self-peptide–MHC signal intensity, and sustained during the life of the cell as long as MHC presentation of
self-peptide is accessible in the periphery.
Is has been debated whether CD5 directly influences T cell
responses, or whether it is simply a marker of TCR–self-peptide–
MHC avidity, established during thymic selection. To explore
this issue in our system, we crossed LLO56 TCR-transgenic mice
onto a CD5-deficient background (CD5−/−). CD4+SP thymocytes
from LLO56/CD5−/− mice express higher levels of CD69 than
their wild-type counterparts, indicating that in the absence of
CD5 these thymocytes perceive a stronger signal during selection. These cells also produce more IL-2 and exhibit greater
ERK phosphorylation in response to non-specific stimulation,
in the absence of CD5 expression (8). Surprisingly, the absence
of CD5 on the LLO56 background (LLO56/CD5−/−) does not
change its apoptotic phenotype at day 7 post-infection, in our
transfer system (unpublished observations). CD5 can be viewed
as a “surrogate marker” of the TCR signal experienced during
thymic education, and it also appears that CD5 (as a negative
regulator) wields some influence on the overall responsiveness of
the T cell post-selection. However, at least in the context of our
TCR-transgenic system, loss of CD5 inhibition is not sufficient to
“rescue” the phenotype of LLO56 at day 7. Clearly, further interrogation of the role of CD5 during an ongoing immune response
is necessary.
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SUMMARY
Using our LLO TCR-transgenic transfer system, we have
demonstrated the importance of heterogeneous responses by
different CD4+ T cells following TCR engagement. The CD4+
TCR-transgenic LLO56, bearing high levels of CD5 reflective
of strong sensing of self-pMHC during thymic development,
responds poorly during a primary response to cognate antigen.
LLO118, on the other hand, has a robust proliferative response
to the same cognate antigen and, at the same time, provides
help during the shaping of the CD8+ T cell response. We see the
responses of LLO56 and LLO118 reverse during secondary infection, where LLO56 dominates the recall response.
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FIGURE 1 | After interaction with self-peptide on thymic APC, both cells perceive a signal strong enough to guide them safely through positive
selection. However, the signal sensed by cell Z is quantitatively or qualitatively stronger, resulting in greater CD5 expression on the mature thymocyte Z, relative to
mature thymocyte X. Upon egress from the thymus, these differing CD5 levels are sustained. In the periphery, both naïve T cells are maintained via tonic signaling
(i.e., periodic TCR recognition of self-pMHC). Upon initial TCR recognition of the same peptide, cell Z exhibits increased levels of phosphorylated ERK and produces
higher amounts of IL-2, relative to cell X. However, by the peak of the immune response, cell X is highly proliferative and capable of generating CD8+ T cell help,
whereas cell Z is highly apoptotic and a poor generator of CD8+ T cell help. Some cell Z clones, however, may differentiate into regulatory T cells, due at least in part
to their high expression of CD5. During a recall response, memory cell Z now proliferates strongly in response to the same cognate antigen sensed during the
primary immune response, while proliferation of cell X is negligible.

We have highlighted only these two distinct cell fates using
our system; however, there is ostensibly a whole “spectrum” of
possible CD4+ T cell responses to recognition of cognate antigen during infection, adding necessary diversity to the immune
system’s response to pathogens. Two such outcomes, along
the spectrum of possible CD4+ T cell responses, are mapped
in Figure 1. Importantly, this spectrum of fates includes
activation of cells that respond robustly to acute insults, cells
that preferentially become memory cells, cells specialized in
providing CD8+ T cell help, and cells more easily drawn into
a Treg fate, just to name a few. These properties are not necessarily mutually exclusive and are determined in large part by
recognition of self-peptide during thymic selection. A strong
case has also been made for the role of cross-reactivity (that

Frontiers in Immunology | www.frontiersin.org

is, the ability of one TCR to recognize multiple pMHC) during
thymic selection. It should also be considered that increased
CD5 expression on LLO56 could be due, at least in part, to an
ability of LLO56 to cross-react more strongly with self-antigens
in the thymus (37–40).
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